NEXT Oncology expands phase I program with VCS partnership

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NEXT Oncology and Virginia Cancer Specialists have joined forces, launching NEXT Virginia, a cancer clinic, in September 2021.

This partnership will also help expand VCS’s phase I and developmental therapeutics cancer research program and bring the latest in new agents and anticancer treatments to the VCS Research Institute. 

The expanded phase I program will begin this fall, while the stand-alone NEXT Virginia clinic, adjacent to Virginia Cancer Specialists, is built. 

NEXT Virginia is headed by Alex Spira, co-director of the VCS Research Institute, who is the site’s clinical director and CEO. Spira is also the director of the VCS thoracic and phase I program and a clinical assistant professor at John Hopkins.

NEXT Oncology has relationships with both Texas Oncology and Virginia Cancer Specialists, both of which are practices in the US Oncology Network. The new clinic will be located at 8613 Lee Highway in Fairfax.

Table of Contents

YOU MAY BE INTERESTED IN

Thomas J. Lynch Jr. and Howard A. “Skip” Burris III lead two institutions that couldn’t be more different—an NCI-designated Comprehensive Cancer Center on one side of the country and a for-profit research enterprise on the other—but they stay up at nights worrying about the same thing.
In back-to-back congressional hearings earlier this week, HHS Secretary Robert F. Kennedy Jr. said that the massive staff and budget cuts over which he has presided during his nearly four months on the job as well as even bigger cuts still looming on the horizon are a part of a single plan.
Natalie Phelps, a 43-year-old mother of two, has stage 4 colorectal cancer. She has become a central figure in the controversy over the dysfunction the Trump administration’s RIFs and budget cuts have brought to NIH. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login